Brief: Verrica Announces Pricing Of $32.5 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants
Feb 21 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA ANNOUNCES PRICING OF $32.5 MILLION UNDERWRITTEN
OFFERING
OF COMMON STOCK AND PRE-FUNDED WARRANTS
* VERRICA PHARMACEUTICALS INC - OFFERING IS EXPECTED TO
CLOSE ON
OR ABOUT FEBRUARY 23, 2023
Source text for Eikon: ID:nGNX4Y2kZ9
Further company coverage: VRCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data